as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
0.18%
Downside
2.37%
Upside
52 Week's Low
52 Week's High
15.08%
Downside
17.07%
Upside
Check Qiagen NV market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.7B
EPS (TTM)
2.3589
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.33%
PE Ratio (TTM)
24.07
Industry PE ratio
19.200384615384614
PEG Ratio
0.3032
EBITDA
1.0B
Revenue (TTM)
2.1B
Profit Margin
19.58%
Return On Equity TTM
11.29%
Track how Qiagen NV P/E has moved over time to understand its valuation trends.
Qiagen NV in the last 5 years
Lowest (17.44x)
March 31, 2022
Industry (19.20x)
November 14, 2025
Today (24.07x)
November 14, 2025
Highest (27.19x)
September 30, 2025
Today’s Price to Earnings Ratio: 24.07x
Compare market cap, revenue, PE, and other key metrics of Qiagen NV with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $9.7B | -11.82% | 24.07 | 19.58% | |
| BUY | $57.0B | 54.63% | 56.5 | 24.65% | |
| BUY | $220.9B | 18.74% | 34.01 | 15.02% | |
| BUY | $38.1B | 28.53% | 30.75 | 8.07% | |
| BUY | $43.0B | 33.33% | 35.48 | 17.97% |
The Qiagen NV stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Qiagen NV investment value today
Current value as on today
₹1,07,551
Returns
₹7,551
(+7.55%)
Returns from Qiagen NV Stock
₹2,356 (+2.36%)
Dollar Returns*
₹5,194 (+5.19%)
Based on 25 analysts
60.00%
Buy
40.00%
Hold
0.00%
Sell
Based on 25 analysts, 60% of analysts recommend a 'BUY' rating for Qiagen NV. Average target price of $50.79
Get share price movements and forecasts by analysts on Qiagen NV.
What analysts predicted
12.76%UPSIDE
Target Price
$50.79
Current Price
$44.31
Analyzed by
25 Analysts
Target
$50.79
Qiagen NV target price $50.79, a slight upside of 12.76% compared to current price of $44.31. According to 25 analysts rating.
Search interest for Qiagen NV Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 20 October
Mon, 07:00 PM
-QIAGEN collaborates with Incyte to develop a novel diagnostic panel for rare blood cancers using next-generation sequencing technology.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, 88.32M → 130.04M (in $), with an average increase of 11.5% per quarter
Price Rise
![]()
In the last 7 days, QGEN stock has moved up by 2.5%
Against Peers
![]()
In the last 3 years, Idexx Laboratories, Inc. has given 61.5% return, outperforming this stock by 73.6%
Against Peers
![]()
In the last 1 year, Idexx Laboratories, Inc. has given 66.7% return, outperforming this stock by 61.5%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 533.54M → 532.58M (in $), with an average decrease of 0.2% per quarter
| Organisation | Qiagen NV |
| Headquarters | Hulsterweg 82, Venlo, Netherlands, 5912 PL |
| Industry | Health Technology |
| CEO | Mr. Thierry Bernard |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Thierry Bernard | CEO, MD & Member of Management Board |
Dr. Dominic John | Vice President of Marketing & Product Management |
Ms. Stephany Foster | Senior VP & Head of Human Resources |
Dr. Thomas Theuringer | Senior Director & Head of External Communications |
Mr. Jean-Pascal Viola | Senior VP & Head of Corporate Strategy and Business Development |
Dr. Jonathan G. Sheldon Ph.D. | Senior VP & Head of the QIAGEN Digital Insights Business Area |
Dr. Roland Sackers | CFO, MD & Member of Management Board |
Mr. Antonio Santos | Senior VP & Head of Global Operations |
Mr. John Gilardi | VP & Head of Corporate Communications |
Dr. Thomas Schweins | Senior Vice President of Life Science Business Area |
Qiagen NV share price today is $44.31 as on at the close of the market. Qiagen NV share today touched a day high of $45.36 and a low of $44.23.
Qiagen NV share touched a 52 week high of $51.88 on and a 52 week low of $37.63 on . Qiagen NV stock price today i.e. is closed at $44.31,which is 14.58% down from its 52 week high and 17.75% up from its 52 week low.
Qiagen NV market capitalisation is $0.01T as on .
Indian investors can start investing in Qiagen NV (QGEN) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Qiagen NV stock (as per the Rupee-Dollar exchange rate as on ).
Based on Qiagen NV share’s latest price of $44.31 as on November 15, 2025 at 2:29 am IST, you will get 0.2257 shares of Qiagen NV. Learn more about
fractional shares .
Qiagen NV stock has given -11.82% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?